current glp-1 drugs Comparing Ozempic, Wegovy and Other GLP-1 nausea: How to handle
Description
N Engl J Med 392(6):612615 [DOI] [PubMed] [Google Scholar] 28.Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Imamura, S., Hirai, K
Brain endothelial cells regulate glucagon-like peptide 1 entry into the brain via a receptor-mediated process
Diabetes Obes Metab 2019;21:920929 [DOI] [PMC free article] [PubMed] [Google Scholar] 60.Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M
Although this finding is promising, long-term studies are necessary not only in civilian populations but also in populations that do not have Type 2 Diabetes (T2D)
We speculate that a fraction of the purified receptor complex may bind Gs in the absence of the agonist
